Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer-Reference-Cited by-同舟云学术

Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer

Published:2016-01-19 Issue:10 Volume:46 Page:1196-1208
ISSN:0941-1291
Container-title:Surgery Today
language:en
Short-container-title:Surg Today

Author:

Ohtaki Yoichi,Shimizu Kimihiro,Kaira Kyoichi,Nagashima Toshiteru,Obayashi Kai,Nakazawa Seshiru,Kakegawa Seiichi,Igai Hitoshi,Kamiyoshihara Mitsuhiro,Nishiyama Masahiko,Takeyoshi Izumi

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00595-015-1301-5.pdf

Reference41 articles.

1. Asamura H, Goya T, Koshiishi Y, Sohara Y, Eguchi K, Mori M, Nakanishi Y, Tsuchiya R, Shimokata K, Inoue H, Nukiwa T, Miyaoka E. A Japanese lung cancer registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol. 2008;3:46–52.

2. Li L, Ren S, Zhang Y, Guan Y, Zhao J, Liu J, Wang Q, Chen G, Chen H, Xiang J, Fu X. Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET/CT: potential value in the clinic. Lung Cancer. 2013;81:213–7.

3. Miyasaka Y, Suzuki K, Takamochi K, Matsunaga T, Oh S. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer. Eur J Cardiothorac Surg. 2013;44:83–7.

4. Casiraghi M, Travaini LL, Maisonneuve P, Tessitore A, Brambilla D, Agoglia BG, Guarize J, Spaggiari L. Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria? Eur J Cardiothorac Surg. 2011;39:e38–43.

5. Perigaud C, Bridji B, Roussel JC, Sagan C, Mugniot A, Duveau D, Baron O, Despins P. Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer. Eur J Cardiothorac Surg. 2009;36:731–6.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A retrospective study on the effect of Chinese patent medicine combined with conventional treatment on the survival outcomes of 313 patients with stage II–III NSCLC;Aging;2024-03-28

2. Amide Proton Transfer‐Weighted Imaging and Multiple Models Intravoxel Incoherent Motion‐Based ¹⁸F‐FDG PET/MRI for Predicting Progression‐Free Survival in Non‐Small Cell Lung Cancer;Journal of Magnetic Resonance Imaging;2023-10-18

3. A Risk Model to Predict the Delivery of Adjuvant Chemotherapy Following Lung Resection in Patients With Pathologically Positive Lymph Nodes;Seminars in Thoracic and Cardiovascular Surgery;2022-03

4. Predictive Risk Factors for Early Recurrence of Stage pIIIA-N2 Non-Small Cell Lung Cancer;Cancer Management and Research;2021-11

5. Lymphovascular invasion is an independent prognostic factor for survival in pathologically proven N2 non-small cell lung cancer;Swiss Medical Weekly;2021-02-04